October 11, 2021

Flexion Therapeutics, Inc. (FLXN) has seen an increase of 73.36% in the premarket. However, the last trading session closed at $5.78 with an incline of 2.3%. FLXN Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) On 1st October 2021, FLXN announced equity incentive awards totaling 6,315 restricted stock units to three new employees. The Compensation …

Flexion Therapeutics, Inc. (FLXN) inclined to 73.36% in the premarket – Here’s why? Read More »

Yatsen Holding Limited (YSG) stock soared 3.72% in the pre-market trading session at the price of $3.90 despite no fundamental reason. The last published news on the company’s website was its financial results for the second quarter of 2021. YSG is an international leader and the most famous beauty market in China. It aims to produce …

Yatsen Holding Limited (YSG) Stock Surged 3.72% Pre-Market, Here’s Why     Read More »

Bit Digital, Inc. (BTBT) has experienced an incline of 3.35% in the premarket today. However, the last trading session closed at $11.35 with an increase of 2.9%. BTBT Announces Closing of $80 Million Private Placement On 5th October 2021, BTBT reported that the referral program with institutional investors for the sale of 13,490,728 ordinary shares …

Bit Digital, Inc. (BTBT) shares are inclining in the premarket – Reasons behind it! Read More »

ThermoGenesis Holdings Inc. (NASDAQ: (THMO) stock declined by 1.09% at the last close whereas the THMO stock price remained unchanged in the pre-market trading session. ThermoGenesis Holdings creates, licenses, and sells automated technology for CAR-T and other cell-based treatments. The company now offers a comprehensive suite of automated clinical biobanking, point-of-care apps, and immuno-oncology automation …

ThermoGenesis Holdings Inc. (THMO) stock declines on Friday, Here’s Why Read More »

Alibaba Group Holding Limited (BABA) has experienced an incline of 5.56% in the premarket today. However, the last trading session concluded at $161.52 with an increase of 3.54%. Investment of RMB100 billion to Promote Common Prosperity On 3 September 2021, BABA announced an RMB 100 billion (US$15.5 billion) investment in ten important programs aimed at …

Alibaba Group Holding Limited (BABA) has skyrocketed in premarket – What’s going on? Read More »

Allogene Therapeutics, Inc. (ALLO) stock declined 0.84% in the pre-market trading session at the price of $13.02 despite no fundamental reason. ALLO is a clinical-stage biotechnology company that develops AlloCAR T medicines to treat cancer.  FDA Clinical Hold of AlloCAR T Trials  On 7th October 2021, ALLO reported the clinical hold by U.S. Food and Drug Administration on the AlloCAR T clinical …

Allogene Therapeutics, Inc. (ALLO) Stock Plunged 0.84% Pre-Market, Here’s Why Read More »